(Reuters) - PHILADELPHIA, July 27 - Medical technology company Medtronic Inc. said on Friday that it would acquire Kyphon Inc. for $3.9 billion to expand its spinal treatment business.
Medtronic will acquire all of medical device maker Kyphon's outstanding stock and pay about $71 per share in cash. The offer represents a 32 percent premium over Kyphon's closing price on Thursday, the company said.
Read more at Reuters.com Mergers News
Medtronic will acquire all of medical device maker Kyphon's outstanding stock and pay about $71 per share in cash. The offer represents a 32 percent premium over Kyphon's closing price on Thursday, the company said.
Read more at Reuters.com Mergers News
No comments:
Post a Comment